Regencell Bioscience Holdings Ltd cotiza a 7.35 USD y tiene una capitalización bursátil de $3.6B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism …
| Periodo | 2026-10 | 2026-06 | 2025-11 | 2025-07 |
|---|---|---|---|---|
| Real | — | — | — | — |
| Estimado | — | — | — | — |
| Sorpresa | — | — | — | — |
| Métrica | RGC | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -73.8% | -40.4% | -33.4% |
| ROA | -62.3% | -32.0% | -30.3% |
| Current Ratio | 7.39 | 2.84 | +4.55 |
| Debt / Equity | — | 0.28 | — |